Published January 2002

ICOS joins NASDAQ 100

Herald Business Journal Staff

Bothell-based ICOS Corp. on Dec. 17 became the first Snohomish County company named to the NASDAQ 100, the index viewed as a proxy for the stock market’s technology sector.

ICOS was among 13 companies named to the index to replace 13 that were deleted Dec. 24.

Among the newcomers were Cephalon, a Pennsylvania biotechnology company, and Symantec, the Internet security company. Seattle’s RealNetworks Inc. and California’s 3Com Corp. were among those dropped.

ICOS, which has eight drugs in development, has grown in just over a decade to employ about 465 people. It has a market capitalization of about $3.4 billion. The ICOS drug candidate closest to market release is the impotence drug Cialis, which the company is developing in partnership with Eli Lilly. Cialis is awaiting approval from the U.S. Food and Drug Administration.

Back to the top/January 2002 Main Menu